Correction: A consensus statement from the Japan Diabetes Society (JDS): a proposed algorithm for pharmacotherapy in people with type 2 diabetes

Affiliations

¹ Diabetes and Metabolism Information Center, Diabetes Research Center, National Center for Global Health and Medicine, Tokyo, Japan.
² Department of Diabetes, Metabolism and Endocrinology, Kumamoto University Hospital, Kumamoto, Japan.
³ Division of Endocrinology, Metabolism, Hematological Sciences and Therapeutics, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
⁴ Department of Health Data Science, Graduate School of Data Science, Yokohama City University, Kanagawa, Japan.
⁵ Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
⁶ Department of Diabetes and Endocrinology, Juntendo University Urayasu Hospital, Chiba, Japan.
⁷ Department of Diabetes, Endocrinology and Metabolism and Department of Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Gifu, Japan.
⁸ Division of Diabetes, Metabolism and Endocrinology, Jikei University School of Medicine, Tokyo, Japan.
⁹ Division of Diabetes, Department of Internal Medicine, Aichi Medical University, Aichi, Japan.
¹⁰ Department of Diabetes, Metabolism and Endocrinology, Tokyo Medical University, Tokyo, Japan.
¹¹ Department of Diabetes and Metabolic Diseases, University of Tokyo Graduate School of Medicine, Tokyo, Japan.

^# Contributed equally.

Published Erratum

Ryotaro Bouchi et al. Diabetol Int. 2023.

. 2023 Jul 14;14(4):446.

doi: 10.1007/s13340-023-00644-y. eCollection 2023 Oct.

¹ Diabetes and Metabolism Information Center, Diabetes Research Center, National Center for Global Health and Medicine, Tokyo, Japan.
² Department of Diabetes, Metabolism and Endocrinology, Kumamoto University Hospital, Kumamoto, Japan.
³ Division of Endocrinology, Metabolism, Hematological Sciences and Therapeutics, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
⁴ Department of Health Data Science, Graduate School of Data Science, Yokohama City University, Kanagawa, Japan.
⁵ Department of Diabetes, Endocrinology and Nutrition, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
⁶ Department of Diabetes and Endocrinology, Juntendo University Urayasu Hospital, Chiba, Japan.
⁷ Department of Diabetes, Endocrinology and Metabolism and Department of Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Gifu, Japan.
⁸ Division of Diabetes, Metabolism and Endocrinology, Jikei University School of Medicine, Tokyo, Japan.
⁹ Division of Diabetes, Department of Internal Medicine, Aichi Medical University, Aichi, Japan.
¹⁰ Department of Diabetes, Metabolism and Endocrinology, Tokyo Medical University, Tokyo, Japan.
¹¹ Department of Diabetes and Metabolic Diseases, University of Tokyo Graduate School of Medicine, Tokyo, Japan.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.1007/s13340-022-00605-x.].

A consensus statement from the Japan Diabetes Society (JDS): a proposed algorithm for pharmacotherapy in people with type 2 diabetes.
Bouchi R, Kondo T, Ohta Y, Goto A, Tanaka D, Satoh H, Yabe D, Nishimura R, Harada N, Kamiya H, Suzuki R, Yamauchi T. Bouchi R, et al. Diabetol Int. 2022 Dec 23;14(1):1-14. doi: 10.1007/s13340-022-00605-x. eCollection 2023 Jan. Diabetol Int. 2022. PMID: 36636161 Free PMC article. No abstract available.